Literature DB >> 28797455

Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database.

Mark A Ellis1, Evan M Graboyes1, Terry A Day1, David M Neskey2.   

Abstract

OBJECTIVES: Mucoepidermoid carcinoma (MEC) is an uncommon malignancy that most commonly occurs in the parotid gland followed by the minor salivary glands of the upper aerodigestive tract, most notably in the oral cavity (OC) and oropharynx (OP). Because of its rarity, few studies have been performed that are specific to MEC within the OC and OP. The objective of this study is to describe the tumor characteristics and prognostic features for MEC of the OC and OP.
MATERIALS AND METHODS: The National Cancer Database (NCDB) was used for this study. The primary outcome measure was 5-year overall survival (OS). The secondary outcome measure was occult nodal disease. Fischer's exact tests, chi-square tests, log-rank tests and Cox proportional hazards analyses were performed.
RESULTS: We identified 3005 patients with MEC of the OC/OP. The 5-year overall survival for MEC of the OC and OP was 87%. Increasing age, male sex, Charlson/Deyo comorbidity score of 2+, clinical T3-4 tumors, nodal+disease, high grade tumors and positive margins were independently associated with decreased 5-year OS. Occult nodal disease occurred in 14.1% and 17.3% of high grade and clinical T3-T4 tumors respectively.
CONCLUSION: MEC of the OC/OP has an excellent survival as the majority of these patients have low/intermediate grade and early stage disease. Negative prognosticators include increasing age, male sex, Charlson/Deyo comorbidity score of 2+, clinical T3-4 tumors, nodal+ disease, high grade tumors and positive margins. Our findings justify strong consideration of prophylactic neck dissection for high grade and clinical T3-4 tumors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Minor salivary glands; Mucoepidermoid carcinoma; National cancer database; Occult nodal disease; Oral cavity; Oropharynx; Overall survival

Mesh:

Year:  2017        PMID: 28797455      PMCID: PMC5949444          DOI: 10.1016/j.oraloncology.2017.07.025

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  17 in total

1.  Mucoepidermoid carcinoma of the salivary glands--clinical review of 42 cases.

Authors:  Horst Kokemueller; Niels Brueggemann; Gwen Swennen; André Eckardt
Journal:  Oral Oncol       Date:  2005-01       Impact factor: 5.337

2.  Prognostic factors in mucoepidermoid carcinoma of the salivary glands.

Authors:  Catherine H McHugh; Dianna B Roberts; Adel K El-Naggar; Ehab Y Hanna; Adam S Garden; Merrill S Kies; Randal S Weber; Michael E Kupferman
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

3.  Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.

Authors:  Anil K D'Cruz; Richa Vaish; Neeti Kapre; Mitali Dandekar; Sudeep Gupta; Rohini Hawaldar; Jai Prakash Agarwal; Gouri Pantvaidya; Devendra Chaukar; Anuja Deshmukh; Shubhada Kane; Supreeta Arya; Sarbani Ghosh-Laskar; Pankaj Chaturvedi; Prathamesh Pai; Sudhir Nair; Deepa Nair; Rajendra Badwe
Journal:  N Engl J Med       Date:  2015-05-31       Impact factor: 91.245

4.  Stage as major long term outcome predictor in minor salivary gland carcinoma.

Authors:  V L Vander Poorten; A J Balm; F J Hilgers; I B Tan; R B Keus; A A Hart
Journal:  Cancer       Date:  2000-09-15       Impact factor: 6.860

5.  Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan.

Authors:  Marco Guzzo; Salvatore Andreola; Grazia Sirizzotti; Giulio Cantu
Journal:  Ann Surg Oncol       Date:  2002-08       Impact factor: 5.344

6.  Update on selected salivary gland neoplasms.

Authors:  Jonathan B McHugh; Daniel W Visscher; E Leon Barnes
Journal:  Arch Pathol Lab Med       Date:  2009-11       Impact factor: 5.534

7.  A prognostic index for predicting lymph node metastasis in minor salivary gland cancer.

Authors:  Shane Lloyd; James B Yu; Douglas A Ross; Lynn D Wilson; Roy H Decker
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

8.  High incidence of lymph node metastasis in major salivary gland cancer.

Authors:  Eberhard Stennert; Dilek Kisner; Markus Jungehuelsing; Orlando Guntinas-Lichius; Ursula Schröder; Hans Edmund Eckel; Jens Peter Klussmann
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-07

9.  Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients.

Authors:  Michelle M Chen; Sanziana A Roman; Julie A Sosa; Benjamin L Judson
Journal:  Head Neck       Date:  2013-06-14       Impact factor: 3.147

10.  Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.

Authors:  H Michael Baddour; Stacey A Fedewa; Amy Y Chen
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-01       Impact factor: 6.223

View more
  4 in total

1.  Mucoepidermoid carcinoma: Evaluating the prognostic impact of primary tumor site.

Authors:  Ximena Mimica; Avery Yuan; Ashley Hay; Nora Katabi; Daniella Karassawa Zanoni; Cristina Valero; Jatin P Shah; Richard J Wong; Marc A Cohen; Snehal G Patel; Ian Ganly
Journal:  Oral Oncol       Date:  2021-11-09       Impact factor: 5.337

Review 2.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

3.  Diagnostic and Prognostic Utility of 18F-FDG PET/CT in Recurrent Salivary Gland Cancers.

Authors:  Reiko Nakajima; Snehal G Patel; Nora Katabi; Stephanie Flukes; Audrey Mauguen; Ian Ganly; Heiko Schöder
Journal:  AJR Am J Roentgenol       Date:  2021-04-07       Impact factor: 6.582

Review 4.  Advance oropharyngeal mucoepidermoid carcinoma in a 9-year-old boy: A case report and review of literature.

Authors:  Abdulrazak Ajiya; Iliyasu Yunusa Shuaibu; Mansur Adamu Yahuza
Journal:  Afr J Paediatr Surg       Date:  2022 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.